MedPath

Glyburide

Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg For Oral Use

Approved
Approval ID

04201349-2a01-4fc1-9920-1ef7376d352f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2014

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glyburide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33261-209
Application NumberANDA090937
Product Classification
M
Marketing Category
C73584
G
Generic Name
Glyburide
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 4, 2014
FDA Product Classification

INGREDIENTS (5)

GLYBURIDEActive
Quantity: 5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT

Glyburide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33261-813
Application NumberANDA090937
Product Classification
M
Marketing Category
C73584
G
Generic Name
Glyburide
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 4, 2014
FDA Product Classification

INGREDIENTS (5)

GLYBURIDEActive
Quantity: 2.5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glyburide - FDA Drug Approval Details